Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence

Among the pharmaceutical options available for treatment of ovarian cancer, attention has been increasingly focused on trabectedin (ET-743), a drug which displays a unique mechanism of action and has been shown to be active in several human malignancies. Currently, single agent trabectedin is approv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mascilini, Floriana, Amadio, Giulia, Di Stefano, Maria Grazia, Ludovisi, Manuela, Di Legge, Alessia, Conte, Carmine, De Vincenzo, Rosa, Ricci, Caterina, Masciullo, Valeria, Salutari, Vanda, Scambia, Giovanni, Ferrandina, Gabriella
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2014
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103925/
https://ncbi.nlm.nih.gov/pubmed/25050069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S51550
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares